Stress responsiveness of hypothalamic corticotrophin-releasing factor and pituitary pro-opiomelanocortin mRNAs following high-dose glucocorticoid treatment and withdrawal in the rat
- PMID: 2280210
- DOI: 10.1677/joe.0.1270407
Stress responsiveness of hypothalamic corticotrophin-releasing factor and pituitary pro-opiomelanocortin mRNAs following high-dose glucocorticoid treatment and withdrawal in the rat
Abstract
In-situ hybridization with synthetic oligonucleotide probes was used to determine the mRNA content of corticotrophin-releasing factor (CRF) and proenkephalin A mRNA in the paraventricular nucleus, and of pro-opiomelanocortin (POMC) mRNA in the anterior pituitary gland of male rats immediately after, and during recovery from, chronic high-dose prednisolone treatment. Levels of transcripts for mRNA for both CRF and POMC were markedly reduced after the treatment, but there was a rapid return to control values for CRF mRNA within 18 h of steroid withdrawal. In untreated animals, the stressful stimulus of i.p. hypertonic saline increased CRF and proenkephalin A mRNA within 4 h with no significant difference in response seen whether the tissues were removed at 13.00 or 20.00 h. The increase in POMC mRNA did not reach statistical significance in these animals. Although prednisolone resulted in a marked reduction of basal CRF mRNA, the stress-induced increment of CRF mRNA remained comparable with that found in untreated animals. On the day following cessation of prednisolone treatment at 09.00 h, basal and stress levels of CRF mRNA were significantly higher in rats killed at 20.00 h than at 13.00 h. Proenkephalin A mRNA transcripts were below quantifiable levels of detection in control or non-stressed prednisolone-treated animals at all the time-points studied. Stress, however, resulted in the accumulation of proenkephalin A mRNA in control animals. This response was inhibited by prednisolone treatment and only returned 18 h after withdrawal. Prednisolone treatment reduced POMC mRNA below the levels detected in untreated animals, with no detectable response to stress.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.J Physiol. 1988 Sep;403:511-23. doi: 10.1113/jphysiol.1988.sp017261. J Physiol. 1988. PMID: 3267021 Free PMC article.
-
Onset of glucocorticoid responsiveness of anterior pituitary corticotrophs during development is scheduled by corticotropin-releasing factor.Endocrinology. 1989 Jun;124(6):2686-92. doi: 10.1210/endo-124-6-2686. Endocrinology. 1989. PMID: 2524376
-
Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat.J Endocrinol. 1989 Sep;122(3):705-11. doi: 10.1677/joe.0.1220705. J Endocrinol. 1989. PMID: 2809478
-
Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin A messenger RNA.Neuropeptides. 1989 Jul;14(1):17-20. doi: 10.1016/0143-4179(89)90029-2. Neuropeptides. 1989. PMID: 2789345
-
Expression of corticotropin-releasing factor mRNA in response to stress.Ciba Found Symp. 1993;172:173-87; discussion 187-98. doi: 10.1002/9780470514368.ch9. Ciba Found Symp. 1993. PMID: 8491086 Review.
Cited by
-
Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats.J Clin Invest. 1995 Jul;96(1):231-8. doi: 10.1172/JCI118026. J Clin Invest. 1995. PMID: 7615792 Free PMC article.
-
Corticotropin-releasing factor and glucocorticoid receptor (GR) gene expression in the paraventricular nucleus of immune-challenged transgenic mice expressing type II GR antisense ribonucleic acid.J Mol Neurosci. 1997 Jun;8(3):165-79. doi: 10.1007/BF02736831. J Mol Neurosci. 1997. PMID: 9297630
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous